US 9198976
Polysaccharide-protein conjugate vaccines
granted A61KA61K2039/6037A61K2039/6087
Quick answer
US patent 9198976 (Polysaccharide-protein conjugate vaccines) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/6037, A61K2039/6087, A61K2039/627, A61K39/00